Effect of Recombinant Human Erythropoietin on Quality of Life in Cancer Patients Receiving Chemotherapy Gregoris Iconomou, PhD, Angelos Koutras, MD,

Slides:

Advertisements

Similar presentations

Treatment of postherpetic neuralgia: a review of therapeutic options Charles E. Argoff, MD, Nathaniel Katz, MD, Miroslav Backonja, MD Journal of Pain and.

Advertisements

Comparison of the Constipation Assessment Scale and Plain Abdominal Radiography in the Assessment of Constipation in Advanced Cancer Patients Kittiphon.

The Relationship Between Depression and Pain Language in Cancer and Chronic Non- Cancer Pain Patients Thomas C. Sist, DDS, Gerard A. Florio, PhD, Marguerite.

Oropharyngeal Mucositis Pain Treatment with Transdermal Buprenorphine in Patients After Allogeneic Stem Cell Transplantation Samuel Vokurka, MD, PhD

Cancer-Related Symptom Clusters, Eosinophils, and Survival in Hepatobiliary Cancer: An Exploratory Study Jennifer L. Steel, PhD, Kevin H. Kim, PhD, Mary.

Symptom Cluster and Quality of Life in Multiple Sclerosis

Managing Metastatic Bone Pain: The Role of Bisphosphonates

Managing Metastatic Bone Pain: The Role of Bisphosphonates

Wen Jing Chung, MD, MS, Gregory H. Pharo, DO

Effects of High Dose Opioids and Sedatives on Survival in Terminally Ill Cancer Patients Tatsuya Morita, MD, Junichi Tsunoda, MD, Satoshi Inoue, MD,

Evolution of Cancer-Related Symptoms Over an 18-Month Period

Comparison of Tropisetron and Chlorpromazine Combinations in the Control of Nausea and Vomiting in Patients with Advanced Cancer Kyriaki Mystakidou,

Psychostimulants for the Management of Cancer-Related Fatigue: A Systematic Review and Meta-Analysis Ollie Minton, MSc, Alison Richardson, PhD, Michael.

Anita L Comley, PhD, RN, AOCN, Elaine DeMeyer, RN, MSN, AOCN

Efficacy of Dexmethylphenidate for the Treatment of Fatigue After Cancer Chemotherapy: A Randomized Clinical Trial Elyse E. Lower, MD, Stewart Fleishman,

Fatigue in Gynecological Cancer Patients During and After Anticancer Treatment Gillian Prue, PhD, James Allen, PhD, Jacqueline Gracey, PhD, Jane Rankin,

What Influences Patients’ Decisions on Artificial Hydration at the End of Life? A Q- Methodology Study Catherine Malia, MSc, Michael I. Bennett, MB, ChB,

Oropharyngeal Mucositis Pain Treatment with Transdermal Buprenorphine in Patients After Allogeneic Stem Cell Transplantation Samuel Vokurka, MD, PhD

Eduardo Bruera, MD, Raul Sala, MD, Odette Spruyt, MD, J

Development and Initial Validation of the Three-Levels-of-Needs Questionnaire for Self- Assessment of Palliative Needs in Patients with Cancer Anna Thit.

Delirium in Terminal Cancer

The Direct and Indirect Costs of Opioid-Induced Constipation

Relationship of hemoglobin levels to fatigue and cognitive functioning among cancer patients receiving chemotherapy Paul B Jacobsen, PhD, Linda L Garland,

Jean-Pierre Van Buyten, MD Journal of Pain and Symptom Management

What Can We Learn About the Spiritual Needs of Palliative Care Patients From the Research Literature? Mark Cobb, MA, Christopher Dowrick, MD, FRCGP,

Transdermal Fentanyl for Chronic Pain in AIDS

David Clark, PhD, Michael Wright, PhD

Redefining Appropriate Treatment Expectations

Treatment of Cancer Pain with Noninvasive Brain Stimulation

Cancer-Related Symptom Clusters, Eosinophils, and Survival in Hepatobiliary Cancer: An Exploratory Study Jennifer L. Steel, PhD, Kevin H. Kim, PhD, Mary.

Jodi L. Hannan, MD, Steven M. Radwany, MD, Terry Albanese, PhD

A Pilot Exploration of the Antiemetic Activity of Olanzapine for the Relief of Nausea in Patients with Advanced Cancer and Pain Steven D. Passik, PhD,

Barriers to Pain Management in a Community Sample of Chinese American Patients with Cancer Janet Edrington, RN, PhD, Angela Sun, MPH, Candice Wong, MD,

The Role of Patients' Expectations in the Development of Anticipatory Nausea Related to Chemotherapy for Cancer Jane T. Hickok, MD, MPH, Joseph A. Roscoe,

Psychometric Properties of the Fatigue Questionnaire EORTC QLQ-FA12 in a Sample of Female Cancer Patients Sophie Kecke, Jochen Ernst, PhD, Jens Einenkel,

Amitriptyline in the Treatment of Chemotherapy-Induced Neuropathic Symptoms Anna-Liisa Kautio, MD, Maija Haanpää, MD, PhD, Tiina Saarto, MD, PhD, Eija.

Barrie R. Cassileth, PhD, Andrew J. Vickers, PhD

Robert L. Jayes, MD, Robert M. Arnold, MD, Erik K. Fromme, MD

Prevalence and Characteristics of Breakthrough Pain in Cancer Patients Admitted to a Hospice Giovambattista Zeppetella, BSc (Hons), MRCGP, Catherine.

The Brief Fatigue Inventory: Comparison of Data Collection Using a Novel Audio Device with Conventional Paper Questionnaire Edward Pallett, PhD, Patricia.

Antonio T. Fernando, MD, Nathan S. Consedine, PhD

Changing M3G/M6G Ratios and Pharmacodynamics in a Cancer Patient During Long- Term Morphine Treatment Gertrud Andersen, MD, Lona L Christrup, PhD, Per.

The Assessment of Cancer Pain in North India

The Impact of Symptoms, Coping Capacity, and Social Support on Quality of Life Experience Over Time in Patients with Lung Cancer Ingela Henoch, RN, PhD,

Richard J Gralla, MD, Frank Griesinger, MD, PhD

U.S. Hospice Benefits Journal of Pain and Symptom Management

The Spiritual Needs Assessment for Patients (SNAP): Development and Validation of a Comprehensive Instrument to Assess Unmet Spiritual Needs Rashmi K.

Gertrud Andersen, MD, Lona Christrup, PhD, Per Sjøgren, MD

Either Called “Chemobrain” or “Chemofog,” the Long-Term Chemotherapy-Induced Cognitive Decline in Cancer Survivors Is Real Andreas A. Argyriou, MD, PhD,

The impact of demographic and disease-specific variables on pain in cancer patients Tone Rustøen, RN, PhD, Sophie D Fosså, MD, Dr Med Sci, Jon Skarstein,

Development and Reliability Testing of the Victoria Bowel Performance Scale (BPS) G. Michael Downing, MD, Craig Kuziemsky, PhD, Mary Lesperance, PhD,

Association Between Symptom Distress and Survival in Outpatients Seen in a Palliative Care Cancer Center J. Lynn Palmer, PhD, Michael J. Fisch, MD, MPH

Margot E. Kurtz, PhD, Jay C. Kurtz, PhD, Charles W

A Scale for Measuring Patient Perceptions of the Quality of End-of-Life Care and Satisfaction with Treatment Daniel P. Sulmasy, OFM, MD, PhD, Jessica.

Propensity Scores: A Practical Method for Assessing Treatment Effects in Pain and Symptom Management Research Melissa M. Garrido, PhD Journal of Pain.

Clinical and Economic Impact of Palliative Care Consultation

The Asia Pacific Hospice Palliative Care Network

Efficacy of Darbepoetin Alfa in Alleviating Fatigue and the Effect of Fatigue on Quality of Life in Anemic Patients with Lymphoproliferative Malignancies

Physical Function in Patients with Cancer

Greek McGill Pain Questionnaire

Treatment of Nausea and Emesis During Cancer Chemotherapy

Gerd Inger Ringdal, PhD, Marit S Jordhøy, MD, Stein Kaasa, PhD

Multidimensional independent predictors of cancer-related fatigue

Impact of Dyspnea, Pain, and Fatigue on Daily Life Activities in Ambulatory Patients with Advanced Lung Cancer Keiko Tanaka, MD, Tatsuo Akechi, MD, PhD,

Fatigue in Patients with Cancers of the Breast or Prostate Undergoing Radical Radiotherapy Patrick Stone, MA, MD, MRCP, Michael Richards, MA, MD, MRCP,

Helping Patients with Advanced Cancer Live with Concerns About Eating: A Challenge for Palliative Care Professionals Jane Hopkinson, PhD, RGN, Jessica.

Does the Medical Record Cover the Symptoms Experienced by Cancer Patients Receiving Palliative Care? A Comparison of the Record and Patient Self-Rating

Associations Between Physical Activity and Quality of Life in Cancer Patients Receiving Palliative Care: A Pilot Survey Sonya S. Lowe, MD, MSc, Sharon.

Fatigue in Gynecological Cancer Patients During and After Anticancer Treatment Gillian Prue, PhD, James Allen, PhD, Jacqueline Gracey, PhD, Jane Rankin,

Gabapentin as an Adjuvant to Opioid Analgesia for Neuropathic Cancer Pain Augusto Caraceni, MD, Ernesto Zecca, MD, Cinzia Martini, MD, Franco De Conno,

Presentation transcript:

Effect of Recombinant Human Erythropoietin on Quality of Life in Cancer Patients Receiving Chemotherapy Gregoris Iconomou, PhD, Angelos Koutras, MD, Antonis Rigopoulos, MD, Apostolos G Vagenakis, MD, Haralabos P Kalofonos, MD, PhD Journal of Pain and Symptom Management Volume 25, Issue 6, Pages 512-518 (June 2003) DOI: 10.1016/S0885-3924(03)00070-8

Fig. 1 Comparison of QOL mean change scores by treatment group: independent sample t-tests. The range of CLAS instruments is 0–100 and of FACT-Fatigue is 0–52. Journal of Pain and Symptom Management 2003 25, 512-518DOI: (10.1016/S0885-3924(03)00070-8)